Synopsis
Synopsis
0
EU WC
0
KDMF
0
VMF
0
Listed Dossiers
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Acetate, Goserelin
2. Goserelin
3. Ici 118630
4. Ici-118630
5. Ici118630
6. Zoladex
1. 145781-92-6
2. Fertilan
3. Zoladex
4. Goserelin (acetate)
5. Goserelin Acetate [jan]
6. 6yuu2pv0u8
7. Dsstox_cid_26736
8. Dsstox_rid_81865
9. Dsstox_gsid_46736
10. 1-9-luteinizing Hormone-releasing Factor (swine), 6-(o-(1,1-dimethylethyl)-d-serine)-, 2-(aminocarbonyl)hydrazide, Acetate (salt)
11. Cas-145781-92-6
12. Ici-118630 Acetate
13. Unii-6yuu2pv0u8
14. Novgos
15. Zoladex La
16. Zoladex (tn)
17. Ncgc00167588-02
18. Ncgc00183275-01
19. Schembl6094
20. Goserelin Acetate (jan/usp)
21. Chembl1200501
22. Dtxsid9046736
23. Goserelin Acetate [vandf]
24. Goserelin Acetate [mart.]
25. Glxc-26187
26. Goserelin Acetate [usp-rs]
27. Goserelin Acetate [who-dd]
28. Tox21_112579
29. Tox21_112937
30. Bdbm50247974
31. Hy-13673a
32. Ici118630
33. Mfcd01747329
34. Cs-4509
35. Goserelin Acetate [orange Book]
36. (d-ser(tbu)6,azagly10)-lhrh Acetate
37. Goserelin Acetate [usp Monograph]
38. D00573
39. 781g926
40. Goserelin Acetate, >=99% (hplc), White Powder
41. Q27265738
42. Goserelin, European Pharmacopoeia (ep) Reference Standard
43. H-pyr-his-trp-ser-tyr-d-ser(tbu)-leu-arg-pro-nhnhconh2 Acoh
44. Goserelin Acetate, United States Pharmacopeia (usp) Reference Standard
45. Goserelin For Nmr Identification, European Pharmacopoeia (ep) Reference Standard
46. 6-[o-(1,1-dimethylethyl)-d-serine]-1-9-luteinizing Hormone-releasing Factor (swine) 2-(aminocarbonyl)hydrazide Acetate (salt)
Molecular Weight | 1329.5 g/mol |
---|---|
Molecular Formula | C61H88N18O16 |
Hydrogen Bond Donor Count | 18 |
Hydrogen Bond Acceptor Count | 18 |
Rotatable Bond Count | 32 |
Exact Mass | 1328.66256879 g/mol |
Monoisotopic Mass | 1328.66256879 g/mol |
Topological Polar Surface Area | 533 Ų |
Heavy Atom Count | 95 |
Formal Charge | 0 |
Complexity | 2590 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antineoplastic Agents, Hormonal
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Norway
Brand Name : Zoladex
Dosage Form : Implant
Dosage Strength : 3.6 mg
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Australia
Brand Name : Zoladex Implant
Dosage Form :
Dosage Strength : 3.6 mg
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Sweden
Brand Name : Zoladex
Dosage Form : IMPLANTS FILLED SYRINGE
Dosage Strength : 10.8 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Zoladex
Dosage Form : IMPLANTS FILLED SYRINGE
Dosage Strength : 10.8 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Zoladex
Dosage Form : IMPLANTS FILLED SYRINGE
Dosage Strength : 10.8 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Zoladex
Dosage Form : Implant
Dosage Strength : 3.6 mg
Packaging : Finish filled syringe
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Sweden
Brand Name : Zoladex
Dosage Form : IMPLANTS FILLED SYRINGE
Dosage Strength : 3.6 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Zoladex
Dosage Form : IMPLANTS FILLED SYRINGE
Dosage Strength : 10.8 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Zoladex
Dosage Form : IMPLANTS FILLED SYRINGE
Dosage Strength : 10.8 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Sweden
Brand Name : Zoladex
Dosage Form : IMPLANTS FILLED SYRINGE
Dosage Strength : 3.6 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DRUG PRODUCT COMPOSITIONS
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?